El Saadany, T.; Lupatsch, J.; Mark, M.; Barbier, M.; Mehra, T.; Schwenkglenks, M.; von Moos, R. A Cost-Effectiveness Analysis of Sotorasib As Second-Line Treatment for Patients With KRAS-G12C-Mutated Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Switzerland. Swiss Med Wkly 2025, 155, 3777.